Botryllamides: Natural product inhibitors of ABCG2

ACS Chemical Biology

Volumn 4, Issue 8, 2009, Pages 637-647

  Henrich, Curtis J ^a,b   Robey, Robert W ^c   Takada, Kentaro ^b   Bokesch, Heidi R ^a,b   Bates, Susan E ^c   Shukla, Suneet ^c   Ambudkar, Suresh V ^c   McMahon, James B ^b   Gustafson, Kirk R ^b  

^a SAIC FREDERICK INC   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ANTINEOPLASTIC AGENT; BOTRYLLAMIDE A; BOTRYLLAMIDE B; BOTRYLLAMIDE C; BOTRYLLAMIDE D; BOTRYLLAMIDE E; BOTRYLLAMIDE F; BOTRYLLAMIDE G; BOTRYLLAMIDE H; BOTRYLLAMIDE I; BOTRYLLAMIDE J; BREAST CANCER RESISTANCE PROTEIN; IODOARYLAZIDOPRAZOSIN 1 125; PRAZOSIN; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CONTROLLED STUDY; DRUG PURIFICATION; DRUG STRUCTURE; FLOW CYTOMETRY; HETERONUCLEAR MULTIPLE BOND CORRELATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE;

ADENOSINE TRIPHOSPHATASES; AMIDES; ATP-BINDING CASSETTE TRANSPORTERS; BIOLOGICAL PRODUCTS; CELL LINE; CELL MEMBRANE; HUMANS; MOLECULAR STRUCTURE; NEOPLASM PROTEINS; STRUCTURE-ACTIVITY RELATIONSHIP;

ASCIDIA; BOTRYLLUS;

EID: 69249090183     PISSN: 15548929     EISSN: None     Source Type: Journal    
DOI: 10.1021/cb900134c     Document Type: Article

References (24)

1. Dean, M., and Annilo, T. (2005) Evolution of the ATP-binding cassette (ABC) transporter superfamily in vertebrates, Annu. Rev. Genomics Hum. Genet. 6, 123-142. (Pubitemid 41397078)
2. Gottesman, M. M., Fojo, T., and Bates, S. E. (2002) Multidrug resistance in cancer: role of ATP-dependent transporters, Nat. Rev. Cancer 2, 48-58. (Pubitemid 37328807)
3. Robey, R. W., Polgar, O., Deeken, J., To, K. W., and Bates, S. E. (2007) ABCG2: determining its relevance in clinical drug resistance, Cancer Metastasis Rev. 26, 39-57. (Pubitemid 46452182)
4. Breedveld, P., Beijnen, J. H., and Schellens, J. H. M. (2006) Use of P-glycoprotein and BCRP inhibitors to improve oral bioavailability and CNS penetration of anticancer drugs, Trends Pharmacol. Sci. 27, 17-24. (Pubitemid 43063120)
5. Hardwick, L. J. A., Velamankanni, S., and van Veen, H. W. (2007) The emerging pharmacotherapeutic significance of the breast cancer resistance protein (ABCG2), Br. J. Pharmacol. 151, 163-174. (Pubitemid 46763043)
6. Dean, M., Fojo, T., and Bates, S. (2005) Tumour stem cells and drug resistance, Nat. Rev. Cancer 5, 275-284. (Pubitemid 40488633)
7. Lobo, N. A., Shimono, Y., Qian, D., and Clarke, M. F. (2007) The biology of cancer stem cells, Annu. Rev. Cell Dev. Biol. 23, 675-699.
8. Rabindran, S. K., He, H., Singh, M., Brown, E., Collins, K. I., Annable, T., and Greenberger, L. M. (1998) Reversal of a novel multidrug resistance mechanism in human colon carcinoma cells by fumitremorgin C, Cancer Res. 58, 5850-5858. (Pubitemid 29006428)
9. Allen, J. D., van Loevezijn, A., Lakhai, J. M., van der Valk, M., van Teilingen, O., Reid, G., Schellens, J. H., Koomen, G. J., and Schinkel, A. H. (2002) Potent and specific inhibition of the breast cancer resistance protein multidrug transporter in vitro and in mouse intestine by a novel analogue of fumitremorgin C, Mol. Cancer Ther. 1, 417-425.
10. Henrich, C. J., Bokesch, H. R., Dean, M., Bates, S. E., Robey, R. W., Goncharova, E. I., Wilson, J. A., and McMahon, J. B. (2006) A high-through-put cell-based assay for inhibitors of ABCG2 activity, J. Biomol. Screening 11, 176-183.
11. Henrich, C. J., Robey, R. W., Bokesch, H. R., Bates, S. E., Shukla, S., Ambudkar, S. V., Dean, M., and McMahon, J. B. (2007) New inhibitors of ABCG2 identified by high-throughput screening, Mol. Cancer Ther. 6, 3271-3278.
12. Newman, D. J., and Cragg, G. M. (2007) Natural products as sources of new drugs over the last 25 years, J. Nat. Prod. 70, 461-477.
13. Lam, K. S. (2007) New aspects of natural products in drug discovery, Trends Microbiol. 15, 279-289. (Pubitemid 46856162)
14. Tan, G., Gyllenhaal, C., and Soejarto, D. D. (2006) Biodiversity as a source of anticancer drugs, Curr. Drug Targets 7, 265-277.
15. McDonald, L. A., Swersey, J. C., Ireland, C. M., Carroll, A. R., Coll, J. C., Bowden, B. F., Fairchild, C. R., and Cornell, L. (1995) Botryllamides A-D, new brominated tyrosine derivatives from styelid ascidians of the genus Botryllus, Tetrahedron 51, 5237-5244.
16. Rao, M. R., and Faulkner, D. J. (2004) Botryllamides E-H, four new tyrosine derivatives from the ascidian Botrylloides tyreum, J. Nat. Prod. 67, 1064-1066.
17. Ejendal, K. F., and Hrycyna, C. A. (2005) Differential sensitivities of the human ATP-binding cassette transporters ABCG2 and P-glycoprotein to cyclosporine A, Mol. Pharmacol. 67, 902-911.
18. Robey, R. W., Honjo, Y., van de Laar, A., Miyake, K., Regis, J. T., Litman, T., and Bates, S. E. (2001) A functional assay for detection of the mitoxantrone resistance protein MXR (ABCG2), Biochim. Biophys. Acta 1512, 171-182. (Pubitemid 32530764)
19. Robey, R. W., Honjo, Y., Morisaki, K., Nadjem, T. A., Runge, S., Risbood, M., Poruchynsky, M. S., and Bates, S. E. (2003) Mutations at amino-acid 482 in the ABCG2 gene affect substrate and antagonist specificity, Br. J. Cancer 89, 1971-1978. (Pubitemid 37533279)
20. Jonker, J. W., Buitelaar, M., Wagenaar, E., van der Valk, M. A., Scheffer, G. L., Scheper, R. J., Plosch, T., Kuipers, F., Elferink, R. P., Rosing, H., Beijnen, J. H., and Schinkel, A. H. (2002) The breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyria, Proc. Natl. Acad. Sci. U.S.A. 99, 15649-15654. (Pubitemid 35403986)
21. Robey, R. W., Steadman, K., Polgar, O., Morisake, K., Blayney, M., Mistry, P., and Bates, S. E. (2004) Pheophorbide a is a specific probe for ABCG2 function and inhibition, Cancer Res. 64, 1242-1246. (Pubitemid 38235589)
22. Alvarez, M., Robey, R., Sandor, V., Nishiyama, K., Matsumoto, Y., Paull, K., Bates, S., and Fojo, T. (1998) Using the National Cancer Institute anticancer drug screen to assess the effect of MRP expression on drug sensitivity profiles, Mol. Pharmacol. 54, 802-814. (Pubitemid 28523172)
23. Shukla, S., Robey, R. W., Bates, S. E., and Ambudkar, S. V. (2006) The calcium channel blockers, 1,4-dihydropyridines, are substrates of the multidrug resistance-linked ABC drug transporter, ABCG2, Biochemistry 45, 8940-8951. (Pubitemid 44100690)
24. Chearwae, W., Shukla, S., Limtrakul, P., and Ambudkar, S. V. (2006) Modulation of the function of the multidrug resistance-linked ATP-binding cassette transporter ABCG2 by the cancer chemopreventive agent curcumin, Mol. Cancer Ther. 5, 1995-2006. (Pubitemid 44336571)